MyBCTeam

Yes, Verzenio (abemaciclib) is a commonly prescribed medication for breast cancer treatment. It's a CDK4/6 inhibitor that works by blocking specific proteins to stop cancer cells from growing. It was the first CDK4/6 inhibitor approved as a standalone therapy for metastatic breast cancer treatment in 2017. Verzenio is taken Show Full Answer

Yes, Verzenio (abemaciclib) is a commonly prescribed medication for breast cancer treatment. It's a CDK4/6 inhibitor that works by blocking specific proteins to stop cancer cells from growing. It was the first CDK4/6 inhibitor approved as a standalone therapy for metastatic breast cancer treatment in 2017. Verzenio is taken as a daily pill and has shown promising results in clinical trials by extending progression-free survival for many patients. Common side effects may include diarrhea, nausea, infections, abdominal pain, fatigue, and low white blood cell counts (neutropenia). Some people may also experience hair loss as a skin-related side effect.

A MyBCTeam member shared their experience: "I start Verzenio next week and was wondering about hair loss. I've heard the diarrhea can be unbearable."

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

New Treatments for Metastatic Breast Cancer

Does Verzenio Cause Hair Loss?